[1] 杨烨,陈景寿,欧晓娟,等.核苷(酸)类似物治疗失代偿期乙型肝炎肝硬化的随访研究.首都医科大学学报,2010,31:573-577.
[2] 江红接.阿德福韦酯治疗乙型肝炎肝硬化致过敏反应1例.肝脏,2014:304-305.
[3] 李磊,刘伟,陈玉涵,等.不同核苷(酸)类似物抗病毒治疗方案治疗失代偿期乙型肝炎肝硬化的临床研究.北京医学,2014,36:1017-1021.
[4] Hulstaert F1, Schwierz C, Nevens F. et al.Should chronic hepatitis B be treated as early as possible？Int J Technol Assess,2013,29:35-41.
[5] 汪平莉,朱春丽.拉米夫定治疗失代偿期乙型肝炎肝硬化的疗效及不良反应.中国老年学杂志,2014,34:1378-1379.
[6] 庄见齐,林秀辉,李涛,等.替比夫定治疗失代偿期乙型肝炎肝硬化30例临床观察.河北医学,2010,16:50-52.
[7] 熊建成,陆志冲.抗 HBV 主动免疫联合核苷(酸)类似物抗病毒治疗ALT 小于2ULN 慢性乙型肝炎2例.肝脏,2015,4:342-342.
[8] 张桂华,苏红宝,赵健,等.鳖甲软肝胶囊联合拉米夫定、阿德福韦酯片治疗失代偿期乙型肝炎肝硬化临床观察.西部中医药,2013,26:1-4.
[9] Takayanagi T.Modeling chronic hepatitis B or C virus infection during antiviral therapy using an analogy to enzyme kinetics: Long-term viral dynamics without rebound and oscillation.Comput Biol Med,2013,43:2021-2027.
[10] 高祥,张齐,王燕,等.膦甲酸钠治疗失代偿期乙型肝炎肝硬化患者50例.实用临床医药杂志,2010,14:105,116.
[11] 葛保民,梁永谦.阿德福韦酯治疗失代偿期乙型肝炎肝硬化伴腹水96例临床分析.海南医学院学报,2010,16:579-580. |
